Sevoflurane for central catheter placement in neonatal intensive care: a randomized trial

Paediatr Anaesth. 2010 Aug;20(8):712-9. doi: 10.1111/j.1460-9592.2010.03334.x.

Abstract

Objective: To compare the efficacy and safety of sevoflurane deep sedation with glucose and nonnutritive sucking (GNNS) in reducing the duration of the procedure and in preventing pain-related effects during peripherally inserted central catheter (PICC) placement.

Background: PICC placement in neonatal intensive care is a delicate and stressful procedure that requires pain prevention. GNNS has been recommended in this situation but remain often inefficient.

Methods: We designed a randomized controlled study in a sixteen-bed pediatric and neonatal unit in a tertiary hospital. Fifty-nine neonates at >28 weeks of gestation with continuous positive airway pressure or invasive mechanical ventilation and requiring PICC placement were included. Patients were randomized to receive inhaled sevoflurane (IS) or glucose and non-nutritive sucking (GNNS). Procedural duration and conditions, hemodynamic and respiratory parameters, occurrence of movements and complications were compared (http://clinicaltrials.gov trial register no. NCT00420693).

Results: The two groups had similar demographics. There were no between-group differences in procedural duration (P = 0.84) despite greater immobility in IS group (P = 0.017). IS was also associated with fewer episodes of hypertension (P = 0.003), tachycardia (P < 0.001), and bradycardia (P = 0.02). Occurrences of hypotension were not different between the groups (P = 0.06). The GNNS group showed more desaturation during the 4 h after the procedure (P = 0.03). Complications during intensive care stay did not differ between groups.

Conclusion: Inhaled sevoflurane does not make easier catheters placement but prevent pain-related symptoms. Because sevoflurane is responsible for hypotension, it requires careful monitoring and treatment adaptation.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anesthetics, Inhalation* / adverse effects
  • Blood Glucose / metabolism
  • Catheterization, Central Venous* / adverse effects
  • Feasibility Studies
  • Female
  • Gestational Age
  • Glucose
  • Hemodynamics / physiology
  • Humans
  • Infant, Newborn
  • Infant, Premature
  • Intensive Care, Neonatal*
  • Male
  • Methyl Ethers* / adverse effects
  • Pain / prevention & control
  • Pain Measurement / drug effects
  • Prospective Studies
  • Respiratory Mechanics / physiology
  • Sevoflurane
  • Sucking Behavior
  • Treatment Outcome

Substances

  • Anesthetics, Inhalation
  • Blood Glucose
  • Methyl Ethers
  • Sevoflurane
  • Glucose

Associated data

  • ClinicalTrials.gov/NCT00420693